HearseDJStewartDABraimbridgeMV. Cellular protection during myocardial ischaemia: The development and characterisation of a procedure for the induction of reversible ischaemic arrest. Circulation1976;54:193–202.
2.
HearseDJStewartDABraimbridgeMV. Myocardial protection during ischaemic cardiac arrest. The importance of magnesium in cardioplegic infusates. J Thorac Cardiovasc Surg1978;75:877–85.
3.
YamamotoFBraimbridgeMVHearseDJ. Calcium and cardioplegia. The optimal calcium content for the St Thomas' Hospital cardioplegic solution. J Thorac Cardiovasc Surg1984;87:908–12.
4.
JyngePHearseDJBraimbridgeMV. Myocardial protection during ischaemic cardiac arrest. A possible hazard with calcium-free cardioplegic infusates. J Thorac Cardiovasc Surg1977;73(6):848–55.
5.
HearseDJStewartDABraimbridgeMV. Myocardial protection during bypass and arrest. A possible hazard with lactate-containing infusates. J Thorac Cardiovasc Surg1976;72:880–4.
6.
MurashitaTHearseDJ. Temperature response studies of the detrimental effects of multidose cardioplegia versus single dose cardioplegic solution in the rabbit heart. J Thorac Cardiovasc Surg1991;102(5):673–83.
7.
KempsfordRDHearseDJ. Protection of the immature heart. Temperature-dependent beneficial or detrimental effects of multidose crystalloid cardioplegia in the neonatal rabbit heart. J Thorac Cardiovasc Surg1990;99(2):269–79.
8.
WalkerDMYellonDM. Ischaemic preconditioning: From mechanism to exploitation. Cardiovasc Res1992;26:734–39.
9.
YellonDMPasiniEFerrariRDowneyJMLatchmanDS. Whole body heat shock protects the isolated perfused rabbit heart. Circulation1990;82(suppl III-463):1839.
10.
YellonDMIliodromitisELatchmanDSVan WinkleDMDowneyJMWilliamsFM. Whole body heat stress fails to limit infarct size in the reperfused rabbit heart. Cardiovasc Res1992;26:342–6.
